Back to calendar
Spyre Therapeutics, Inc. (SYRE) Earnings
SYRE reports earnings on Thursday, August 6, 2026
earnings report
August 6, 2026 · Before Market Open
Q2 2026
Est. EPS: $-0.76
Actual EPS: $-0.74
Company overview
Market Cap$8.5B
SectorHealth Technology
IndustryPharmaceuticals: Major